Andrew Weckstein

6PUBLICATIONS
190CO-AUTHORS
Behavioural epidemiologyEpidemiological methodsCancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseasesChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 06, 2026
Lithium therapy and delayed progression of Alzheimer's disease and related dementias in patients with bipolar disorder and mild neurocognitive disorders.

Andrew R Weckstein, Sinclair Carr, Philip Wang

|Dec 03, 2025
Scalable confounding adjustment in real-world evidence: benchmarking data-adaptive and investigator-specified strategies in a large-scale trial emulation study.

Andrew R Weckstein, Shirley V Wang, Richard Wyss

|Sep 25, 2025
Illustrating an Adaptive Prespecification Framework for Observational Research: Target Trial Emulations Comparing Immunomodulator Treatments for COVID-19.

Andrew R Weckstein, Vera Frajzyngier, Sarah E Vititoe

|Apr 04, 2022
Categorization of COVID-19 severity to determine mortality risk.

Elizabeth M Garry, Andrew R Weckstein, Kenneth Quinto

|Mar 17, 2021
COVID-19 Evidence Accelerator: A parallel analysis to describe the use of Hydroxychloroquine with or without Azithromycin among hospitalized COVID-19 patients.

Mark Stewart, Carla Rodriguez-Watson, Adem Albayrak

|Oct 16, 2020
Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.

David E Gordon, Joseph Hiatt, Mehdi Bouhaddou

Pageof 1

Frequent Collaborators

3 joint publications

Jeremy A Rassen

2 joint publications

Reyna Klesh

1 joint publications

David E Gordon

1 joint publications

Joseph Hiatt